ANXA1 and prostate cancer: As with its pro-survival property, AnxA1 acts as a double-edged sword: secretion of either AnxA1 or Ac2-26 by tumor-associated fibroblasts induces the acquisition of stem-like features in prostate cancer cells, thus leading to a worse prognosis [87].